Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1) is an integral membrane enzyme that catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty acyl-CoA. It is involved in lipid metabolism, specifically cholesterol storage and transport. ACAT1 is a member of the MBOAT family and is expressed ubiquitously. It plays a role in both ketone body synthesis and breakdown. Mutations in ACAT1 can cause beta-ketothiolase deficiency. It is a therapeutic target for atherosclerosis and Alzheimer's disease.
Inhibition of cholesterol esterification
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1).